wegovy tirzepatide or semaglutide Outperforms in Reducing Major Adverse Cardiovascular Events Semaglutide vs Tirzepatide: Key Differences

Results from these clinical studies demonstrated significant improvements in glycaemic control, as indicated by notable reductions in glycated haemoglobin levels (-1.87% to -2.59%, -20 to -28 mmol/mol)

Reserved for patients who need additional effect after lower doses have been optimized

Measuring body fat percentage, lean mass, and waist circumference every 4 weeks provides more complete efficacy assessment than weight alone

Tirzepatide induced larger reductions in body weight vs GLP-1 RAs, ranging from 1.68 kg (95% CI 0.84, 2.52 [ I 2 0%]) with tirzepatide 5 mg to 7.16 kg (95% CI 4.86, 9.46 [ I 2 72%]) with tirzepatide 15 mg (Fig

It's easier than you think

Pens may be kept at room temperature (up to 86F/30C) for a limited time per product labeling